Literature DB >> 8420869

Optic glioma in children: surveillance, resection, or irradiation?

D Jenkin1, S Angyalfi, L Becker, M Berry, R Buncic, H Chan, M Doherty, J Drake, M Greenberg, B Hendrick.   

Abstract

Eighty-seven consecutive children with newly diagnosed optic glioma were managed at University of Toronto hospitals 1958-1990. Overall the 10-year survival, relapse-free survival and freedom from second relapse rates were 84%, 68% and 85%. Twenty-seven patients relapsed or progressed, of whom 40% were free of a second relapse 10 years after the first relapse. Fourteen patients had a second relapse. Thirteen are dead. None survived 5 years after second relapse. Patients with anteriorly located tumors (N = 35), which involved the optic nerve, or chiasm and optic nerves, fared better than those with posteriorly located tumors (N = 52) with spread beyond the chiasm, 10-year survival 95% versus 76%, (p = .02), 10-year relapse-free survival 80% versus 59% (p = .02), respectively. For posterior tumors primary irradiation was more effective than primary subtotal resection for prevention of subsequent relapse, 10-year relapse-free survival 75% versus 41% (p = .02), but salvage therapy was, in part, successful and multivariate analysis of prognostic factors influencing survival for posterior tumors indicated that neither primary resection nor primary irradiation were significant factors. For first relapse, primary irradiation and the presence of neurofibromatosis were the significant favorable factors. Since 1977 and for posterior optic glioma subtotal resection or surveillance were used in 21/29 (72%) patients compared with 4/23 (17%) previously. Ten-year survival rates before and after 1977 were 78% and 67% and 10-year relapse-free survival 64% and 56%, respectively.

Entities:  

Mesh:

Year:  1993        PMID: 8420869     DOI: 10.1016/0360-3016(93)90342-s

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

1.  Visual pathway glioma: an erratic tumour with therapeutic dilemmas.

Authors:  A Shuper; G Horev; L Kornreich; S Michowiz; R Weitz; R Zaizov; I J Cohen
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Neurofibromatosis 1-associated optic pathway gliomas.

Authors:  Ben Shofty; Liat Ben Sira; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-11       Impact factor: 1.475

Review 3.  Pediatric low-grade gliomas.

Authors:  Angela J Sievert; Michael J Fisher
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

4.  Visual outcomes in pediatric optic pathway glioma after conformal radiation therapy.

Authors:  Richard M Awdeh; Erin N Kiehna; Richard D Drewry; Natalie C Kerr; Barrett G Haik; Shengjie Wu; Xiaoping Xiong; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-18       Impact factor: 7.038

5.  Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).

Authors:  K Müller; A Gnekow; F Falkenstein; J Scheiderbauer; I Zwiener; T Pietsch; M Warmuth-Metz; J Voges; G Nikkhah; M Flentje; S E Combs; D Vordermark; M Kocher; R-D Kortmann
Journal:  Strahlenther Onkol       Date:  2013-07-07       Impact factor: 3.621

6.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).

Authors:  Tore Stokland; Jo-Fen Liu; James W Ironside; David W Ellison; Roger Taylor; Kathryn J Robinson; Susan V Picton; David A Walker
Journal:  Neuro Oncol       Date:  2010-09-22       Impact factor: 12.300

7.  Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children.

Authors:  Ting-Rong Hsu; Tai-Tong Wong; Feng-Chi Chang; Donald M Ho; Ren-Bin Tang; Peck-Foong Thien; Kai-Ping Chang
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

Review 8.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 9.  Special issues in the management of gliomas in children with neurofibromatosis 1.

Authors:  I F Pollack; J J Mulvihill
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

10.  Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era.

Authors:  C Cappelli; J Grill; M Raquin; A Pierre-Kahn; A Lellouch-Tubiana; M J Terrier-Lacombe; J L Habrand; D Couanet; R Brauner; D Rodriguez; O Hartmann; C Kalifa
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.